Washington Dc, DCNCT06623981Now EnrollingIRB Ready

Asthma in Children Clinical Trial in Washington Dc, DC

Access cutting-edge asthma in children treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by Children's National Research Institute

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions…

Expert Care in Washington Dc

Access asthma in children specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related asthma in children treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this asthma in children clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This Asthma in Children Study in Washington Dc

The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children under the age of 18 in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: 1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?

Sponsor: Children's National Research Institute

Who Can Participate

Inclusion Criteria

Primary caregiver of the child with asthma seen at the community-based asthma clinic
Female (self-identified)
Black (self-identified)
≥ 18 years of age
English-speaking
PHQ-9 ≥ 8 during standardized screening at the child with asthma's clinic visit Child:
\<18 years old for the duration of the 6-month study period
Publicly insured
Physician-diagnosed persistent asthma

Exclusion Criteria

Acutely suicidal (high risk on the C-SSRS at child's asthma clinic visit)
Bipolar disorder or mania
Schizophrenia
Current substance abuse/dependence
Current serious physical intimate partner violence (IPV)
Lack of capacity to meaningfully participate in study procedures, as assessed by study staff during screening Child:
Significant medical co-morbidity (e.g., disorders of the cardiorespiratory system, significant developmental delay, diabetes, seizure disorder, and sickle cell disease)
Enrolled in another intervention with a behavioral component and/or novel asthma therapeutics

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT06623981) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Asthma in Children Treatment Options in Washington Dc, DC

If you're searching for asthma in children treatment options in Washington Dc, DC, this clinical trial (NCT06623981) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma in children specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all asthma in children clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Washington Dc, DC

See all ankylosing spondylitis clinical trials recruiting in Washington Dc — not just this study.

Browse Ankylosing Spondylitis Trials in Washington Dc →

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC